SCHEMBL10453124

SCHEMBL10453124

C[C@@H]1O[C@@H]1O[PH](=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9618445 1.00 — —
SCHEMBL9634515 1.00 — —
Imidazole SCHEMBL10964559 0.78 ALDH1A1 (0.42) —
SCHEMBL4931916 0.78 — —
SCHEMBL9634513 0.78 — —
SCHEMBL11395390 0.78 — —
SCHEMBL30834175 0.72 — —
SCHEMBL22393562 0.69 TSHR (0.32) —
SCHEMBL19940053 0.69 — —
SCHEMBL18257899 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969758-B2 Antimicrobial compounds BIOMERIEUX (FR) 2018-05-15 — — US disclosed
US-20170158720-A1 Antimicrobial Compounds BIOMERIEUX (FR) 2017-06-08 — — US disclosed
US-4937367-A Process for the preparation of intermediates for the synthesis of fosfomycin ZAMBON GROUP S.P.A. (IT) 1990-06-26 — — US disclosed
EP-0299484-A1 Process for the preparation of intermediates for the synthesis of fosfomycin ZAMBON GROUP S.p.A. (IT) 1989-01-18 — — EP disclosed
EP-0027597-A1 Mono(2-ammonium-2-hydroxymethyl-1,3-propanediol)(2R-cis)-(3-methyloxiranyl)phosphonate, its preparation and pharmaceutical compositions containing it ZAMBON S.p.A. (IT) 1981-04-29 — — EP disclosed
Send feedback